3 Results for "

Azemiglitazone

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "Azemiglitazone" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-108022
CAS No.: 1133819-87-0
Pureté:  97.35%
Synonyms: MSDC-0602
Azemiglitazone (MSDC-0602) is an orally active thiazolidinedione (TZD) -like molecule, which binds to PPARγ with low binding and activating affinity. Azemiglitazone inhibits mitochondrial pyruvate carrier (MPC), which inhibits Alzheimer’s disease and diminishes nonalcoholic steatohepatitis (NASH) caused liver injury .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-108022A
CAS No.: 1314533-27-1
Pureté:  99.53%
Synonyms: MSDC-0602K
Target:  

Insulin Receptor PPAR

Domaines de recherche:  

Metabolic Disease

Azemiglitazone potassium (MSDC-0602K), a PPARγ-sparing thiazolidinedione (Ps-TZD), binds to PPARγ with the IC50 of 18.25 μM . Azemiglitazone potassium modulates the mitochondrial pyruvate carrier (MPC). Azemiglitazone potassium can be used for the research of fatty liver including dysfunctional lipid metabolism, inflammation, and insulin resistance . Azemiglitazone potassium, an insulin sensitizer, improves insulinemia and fatty liver disease in mice, alone and in combination with Liraglutide .
loading...
    loading...
Cat. No.: HY-108022R
CAS No.: 1133819-87-0
Synonyms: MSDC-0602 (Standard)
Azemiglitazone (Standard) is the analytical standard of Azemiglitazone (HY-108022). This product is intended for research and analytical applications. Azemiglitazone (MSDC-0602) is an orally active thiazolidinedione (TZD) -like molecule, which binds to PPARγ with low binding and activating affinity. Azemiglitazone inhibits mitochondrial pyruvate carrier (MPC), which inhibits Alzheimer’s disease and diminishes nonalcoholic steatohepatitis (NASH) caused liver injury .
loading...
    loading...